Objective The aim of this study was to assess the epidemiological and clinical characteristics of herpes zoster (HZ) and to ...

Objectives To define a clinically meaningful treatment response definition for haemolytic anaemia, that will form part of a ...

Background Although the increased risk of cardiovascular disease in patients with SLE is well-documented, effective tools for ...

Objective To evaluate the safety and durability of telitacicept treatment in patients with SLE by identifying the reasons for ...

Objective Early prediction of long-term outcomes in patients with systemic lupus erythematosus (SLE) remains a great challenge in clinical practice. Our study aims to develop and validate predictive ...

Introduction Osteoporosis and fragility fracture are more frequently found in systemic lupus erythematosus (SLE) patients ...

Objective This study aimed to leverage machine learning algorithms to explore the relationship between anti-double-stranded DNA (anti-dsDNA) immunoglobulin G (IgG) glycosylation and the degree of ...

Background SLE has increased risk of invasive pneumococcal disease due to immune dysregulation and immunosuppression. European Alliance of Associations for Rheumatology recommendations suggest ...

Objective To assess the appropriateness of expanded serological activity eligibility criteria for belimumab use in the UK systemic lupus erythematosus (SLE) population (and possibly other countries), ...

The dysregulated host immune system and treatment with immunosuppressive medications predisposes patients with systemic lupus erythematosus (SLE) to increased risk of infections such as Human ...

Objective Evaluating the potential role of neuromuscular ultrasonography (NMUS) in assessing optic nerve affection in patients with systemic lupus erythematosus (SLE), compared with healthy controls ...

Objectives Belimumab (BEL) is a B-cell modulator targeting the central immunopathogenic pathway in SLE by selectively inhibiting B lymphocyte stimulator and reducing autoreactive B cells that drive ...